康臣葯業集團有限公司（01681）于2025年11月19日更新翌日披露报表，披露当日回购股份的具体情况。公告显示，公司于当日回购20万股普通股，约占已发行股本的0.0236%，每股购回价介乎港币14.33元至14.48元，总金额约287.86万港元。回购后，公司已发行股本仍维持在847,983,407股，未持有库藏股。
公司另披露，该次回购依据2025年5月22日股东大会通过的购回授权。截至目前，公司累计已回购10,668,000股，占授权总数85,126,334股约12.532%。公司确认已遵守上市规则及相关法例程序。
上述公告由公司秘书高海恩签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.